"Efficacy and Safety of Galcanezumab for the Preventive Treatment of Migraine: A Narrative Review." by Vincent Martin

Selected Works of Robert Pallay, MD

Follow Contact

Article

Efficacy and Safety of Galcanezumab for the Preventive Treatment of Migraine: A Narrative Review.

Advances in Therapy (2020)

Vincent Martin, University of Cincinnati
Karen Hamrick Samaan, Lilly USA, LLC, Indianapolis, IN, USA. karen.samaan@lilly.com.
Sheena Aurora, Eli Lilly and Company
Eric M. Pearlman, Lilly USA, LLC, Indianapolis, IN, USA.
Chunmei Zhou, Eli Lilly and Company
Xiaoping Li, Eli Lilly and Company
Robert Pallay, Mercer University

Link

Disciplines

Medicine and Health Sciences and
Internal Medicine

Publication Date

April 21, 2020

DOI

10.1007/S12325-020-01319-9

Citation Information

Vincent Martin, Karen Hamrick Samaan, Sheena Aurora, Eric M. Pearlman, et al.. "Efficacy and Safety of Galcanezumab for the Preventive Treatment of Migraine: A Narrative Review." Advances in Therapy Vol. 37 Iss. 5 (2020) p. 2034 - 2049
Available at: http://works.bepress.com/robert-pallay/2/